- Home
- XERS vs ASPI Comparison
XERS vs ASPI Comparison
Compare XERS & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | ASPI |
|---|---|---|
| Founded | 2005 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | XERS | ASPI |
|---|---|---|
| Price | $7.28 | $7.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $10.43 | ★ $12.00 |
| AVG Volume (30 Days) | 2.3M | ★ 6.6M |
| Earning Date | 03-02-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $266,137,000.00 | $8,383,354.00 |
| Revenue This Year | $44.77 | $108.31 |
| Revenue Next Year | $27.72 | $403.41 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 42.05 | ★ 147.78 |
| 52 Week Low | $3.38 | $3.65 |
| 52 Week High | $10.08 | $14.49 |
Technical Indicators
Market Signals| Indicator | XERS | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 49.69 |
| Support Level | $7.36 | $7.20 |
| Resistance Level | $7.65 | $8.21 |
| Average True Range (ATR) | 0.30 | 0.78 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 18.37 | 19.95 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.